This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Horwitz SM , Ansell SM , Ai WZ , Barnes J , Barta SK , Choi M , Clemens MW , Dogan A , Greer JP , Halwani A , Bradley MH , Hoppe RT , Jacobsen E , Jagadeesh D , Kim YH , Lunning MA , Mehta A , Mehta-Shah N , Oki Y , Olsen EA , Pro B , Rajguru SA , Shanbhag S , Shustov A , Sokol L , Torka P , Wilcox R , William B , Zain J , Dwyer MA , Sundar H
T-Cell Lymphomas, Version 2.2018 Featured Updates to the NCCN Guidelines
JNCCN Journal of the National Comprehensive Cancer Network. 2018 Feb;16(2) :123-135
PMID: 29439173 URL: https://www.ncbi.nlm.nih.gov/pubmed/29439173
AbstractNatural killer (NK)/T-cell lymphomas are a rare and distinct subtype of non-Hodgkin's lymphomas. NK/T-cell lymphomas are predominantly extranodal and most of these are nasal type, often localized to the upper aerodigestive tract. Because extranodal NK/T-cell lymphomas (ENKL) are rare malignancies, randomized trials comparing different regimens have not been conducted to date and standard therapy has not yet been established for these patients. These NCCN Guidelines Insights discuss the recommendations for the diagnosis and management of patients with ENKL as outlined in the NCCN Guidelines for T-Cell Lymphomas.
NotesExport Date: 1 March 2018